Alzheimer's disease: CSF diagnostics can often replace PET when selecting patients for antibody therapy

Alzheimer’s disease: CSF diagnostics can often replace PET when selecting patients for antibody therapy

26 November, 2024 doctor 0 Comments 1 category

Munich – The impending introduction of the first antibody drug Lecanemab in Europe for the treatment of Alzheimer’s disease makes early diagnosis necessary. Doctors from Munich and Vienna propose Alzheimer’s & Dementia: Diagnosis, Assessment &… [weiter lesen]

#Alzheimers #disease #CSF #diagnostics #replace #PET #selecting #patients #antibody #therapy

Tags:
Category: Medical Encyclopedia

Leave a Reply

Related Posts